BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36831533)

  • 1. Modulating T Cell Responses by Targeting CD3.
    Menon AP; Moreno B; Meraviglia-Crivelli D; Nonatelli F; Villanueva H; Barainka M; Zheleva A; van Santen HM; Pastor F
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer.
    Menon AP; Villanueva H; Meraviglia-Crivelli D; van Santen HM; Hellmeier J; Zheleva A; Nonateli F; Peters T; Wachsmann TLA; Hernandez-Rueda M; Huppa JB; Schütz GJ; Sevcsik E; Moreno B; Pastor F
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102198. PubMed ID: 38745854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural basis of T-cell receptor (TCR) activation: An enduring enigma.
    Mariuzza RA; Agnihotri P; Orban J
    J Biol Chem; 2020 Jan; 295(4):914-925. PubMed ID: 31848223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital T-cell receptor immunodeficiencies in man.
    Alarcon B; Terhorst C; Arnaiz-Villena A; Perez-Aciego P; Regueiro JR
    Immunodefic Rev; 1990; 2(1):1-16. PubMed ID: 2142600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells.
    Lund ME; Howard CB; Thurecht KJ; Campbell DH; Mahler SM; Walsh BJ
    BMC Cancer; 2020 Dec; 20(1):1214. PubMed ID: 33302918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR Repertoire Diversity of Peripheral PD-1
    Han J; Duan J; Bai H; Wang Y; Wan R; Wang X; Chen S; Tian Y; Wang D; Fei K; Yao Z; Wang S; Lu Z; Wang Z; Wang J
    Cancer Immunol Res; 2020 Jan; 8(1):146-154. PubMed ID: 31719056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex.
    Blumberg RS; Ley S; Sancho J; Lonberg N; Lacy E; McDermott F; Schad V; Greenstein JL; Terhorst C
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7220-4. PubMed ID: 2144901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstructing the form and function of the TCR/CD3 complex.
    Kuhns MS; Davis MM; Garcia KC
    Immunity; 2006 Feb; 24(2):133-9. PubMed ID: 16473826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between subunit ectodomains promote T cell antigen receptor assembly and protect against degradation in the ER.
    Wileman T; Kane LP; Young J; Carson GR; Terhorst C
    J Cell Biol; 1993 Jul; 122(1):67-78. PubMed ID: 8314847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does T cell receptor clustering impact on signal transduction?
    Goyette J; Nieves DJ; Ma Y; Gaus K
    J Cell Sci; 2019 Feb; 132(4):. PubMed ID: 30745330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo.
    Passariello M; Yoshioka A; Takahashi K; Hashimoto SI; Inoue T; Nakamura K; De Lorenzo C
    J Exp Clin Cancer Res; 2022 Sep; 41(1):269. PubMed ID: 36071464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high affinity Fc epsilon receptor gamma subunit (Fc epsilon RI gamma) facilitates T cell receptor expression and antigen/major histocompatibility complex-driven signaling in the absence of CD3 zeta and CD3 eta.
    Rodewald HR; Arulanandam AR; Koyasu S; Reinherz EL
    J Biol Chem; 1991 Aug; 266(24):15974-8. PubMed ID: 1714902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasmall silica nanoparticles directly ligate the T cell receptor complex.
    Vis B; Hewitt RE; Monie TP; Fairbairn C; Turner SD; Kinrade SD; Powell JJ
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):285-291. PubMed ID: 31871161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in signal transduction caused by a T cell receptor beta chain substitution.
    Reno TA; Ley S; Sugiyama E; Cantagrel A; Blumberg R; Bonventre J; Terhorst C; Yeh ET
    Eur J Immunol; 1990 Jul; 20(7):1417-22. PubMed ID: 1696890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the Docking Site for CD3 on the T Cell Receptor β Chain by Solution NMR.
    He Y; Rangarajan S; Kerzic M; Luo M; Chen Y; Wang Q; Yin Y; Workman CJ; Vignali KM; Vignali DA; Mariuzza RA; Orban J
    J Biol Chem; 2015 Aug; 290(32):19796-805. PubMed ID: 26109064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination immunotherapy strategies for glioblastoma.
    Chan HY; Choi J; Jackson C; Lim M
    J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of accessory mitogenic signaling receptors by the T cell antigen receptor.
    Zhang XM; Berland R; Rosoff PM
    Mol Immunol; 1995 Apr; 32(5):323-32. PubMed ID: 7739570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of assembly of the human T cell receptor-CD3 complex.
    Dong D; Zheng L; Lin J; Zhang B; Zhu Y; Li N; Xie S; Wang Y; Gao N; Huang Z
    Nature; 2019 Sep; 573(7775):546-552. PubMed ID: 31461748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes.
    Feito MJ; Ballester S; Díez-Orejas R; Ojeda G; Criado G; Portolés P; Rojo JM
    Scand J Immunol; 1997 Feb; 45(2):166-74. PubMed ID: 9042429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.